cian healthcare has scheduled a meeting of its Board of Directors on Saturday, May 30, 2026, to consider and approve the audited financial results for the financial year and half year ended March 31, 2026. The meeting will cover both standalone and consolidated financial statements. This disclosure is significant for shareholders as it will provide a comprehensive view of the company's performance for FY26.

The intimation was made pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that the results will be submitted in XBRL mode as required by the exchange regulations.

In conjunction with the board meeting, the company has implemented a trading window closure. Effective from April 01, 2026, the trading window for dealing in the securities of the company remains closed for all designated persons and their immediate relatives. This restriction is in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code.

The trading window will remain closed until 48 hours after the declaration of the audited financial results. This measure is intended to prevent insider trading and ensure market integrity during the period of price-sensitive information disclosure.

Rachit Malhotra, Company Secretary and Chief Compliance Officer, signed the intimation on May 26, 2026, confirming the schedule and the compliance measures in place.